Neoadjuvant immunotherapy for early stage melanoma shows positive results
Immunotherapy before surgery for patients with metastatic melanoma appears to be especially successful. Some 59% of patients respond so well to this therapy that adjuvant treatment is no longer needed, according to the results ...
10 hours ago
0
1